You are viewing: US Veterinary Contract Manufacturing & Research Market analysis

The US Veterinary Contract Manufacturing & Research Market was valued at $345.3 Million in 2026 and projected to reach to $511.7 Million by 2031, representing a compound annual growth rate of 8.2%. The US veterinary contract manufacturing and research market is positioned for sustained growth through 2031, driven by increasing outsourcing trends among veterinary pharmaceutical companies seeking specialized manufacturing expertise and regulatory compliance.

US Veterinary Contract Manufacturing & Research Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Veterinary Contract Manufacturing & Research Market Trends and Insights

  • The US market benefits from robust pharmaceutical innovation, stringent regulatory frameworks, and increasing demand for specialized veterinary therapeutics and biologics.
  • US-based contract manufacturers are capitalizing on outsourcing trends as veterinary pharmaceutical companies seek cost-effective, compliant production and research solutions. Growth in the US market is driven by rising pet ownership, expanding livestock production, and accelerated development of novel veterinary vaccines and treatments.
  • The US maintains a competitive advantage through advanced manufacturing infrastructure, FDA compliance expertise, and established relationships with major veterinary pharmaceutical firms.
  • Between 2026 and 2031, the US market will continue to attract investment in contract research organizations (CROs) and contract manufacturing organizations (CMOs) specializing in animal health applications..

Key Market Statistics

  • CAGR (2026-2031) 8.2% CAGR
  • Market Size, 2026 ~USD 345.3 Million
  • Forecast, 2031 ~USD 511.7 Million
  • Country US

US Veterinary Contract Manufacturing & Research Market Overview

Market Valuation & Growth :

The US veterinary contract manufacturing and research market is valued at $345.3 million in 2026 and is projected to reach $511.7 million by 2031, demonstrating robust expansion at an 8.2% CAGR, outpacing the global growth rate of 7.7%.

Regulatory Excellence & Innovation :

The US market is driven by stringent FDA regulatory frameworks and advanced pharmaceutical innovation capabilities, positioning American contract manufacturers as preferred partners for complex veterinary therapeutics, biologics, and specialized formulations.

Specialized Therapeutics Demand :

Increasing demand for specialized veterinary therapeutics, including companion animal pharmaceuticals and livestock biologics, is fueling growth among US-based contract manufacturers offering comprehensive R&D and manufacturing solutions.

Industry Consolidation & Capacity :

US contract manufacturers are expanding production capacity and investing in advanced technologies to meet growing demand from veterinary pharmaceutical companies seeking outsourced manufacturing and research partnerships.

US Veterinary Contract Manufacturing & Research Market Dynamics

  • The market benefits from strong domestic demand for companion animal therapeutics, livestock biologics, and innovative formulations, supported by robust FDA oversight and quality standards that enhance market credibility. US-based contract manufacturers are capitalizing on their regulatory expertise and advanced infrastructure to capture market share from both domestic and international veterinary pharmaceutical firms.
  • Strategic investments in capacity expansion, technology modernization, and specialized service offerings are expected to accelerate market penetration, with particular growth opportunities in biologics manufacturing, personalized veterinary medicine, and emerging therapeutic categories..

Related Ecosystem

Animal Health

Top Technologies
    Top Companies

      Key Takeaways

      • The US veterinary contract manufacturing & research market is valued at $345.3M in 2026 and will reach $511.7M by 2031, growing at 8.2% CAGR.
      • US market growth is fueled by increased outsourcing of veterinary pharmaceutical development and manufacturing by domestic and international firms.
      • The US benefits from FDA regulatory expertise, advanced infrastructure, and strong demand for pet and livestock health solutions.
      • Between 2026 and 2031, the US market will see expanded investment in specialized CROs and CMOs focused on veterinary biologics and vaccines.

      Veterinary Contract Manufacturing & Research Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment CDMO SERVICES (Service)
      Forecast Period 2026–2031
      Growth Rate CAGR of 7.7% from 2026 to 2031
      Largest Segment CDMO SERVICES (Service)
      Market Size Base Year (Billions) ~USD 6.38 (2026)
      Revenue Forecast (Billions) ~USD 9.24 (2031)
      Segments Covered Service, Type

      US Veterinary Contract Manufacturing & Research Market Report Segmentation

      2 segment dimensions are covered across the global market.

      By Service

      • Cdmo Services
      • Cro Services

      By Type

      • Analytical & Bioanalytical Services And Quality Assurance
      • Discovery & Pre-Clinical Studies
      • Manufacturing
      • Packaging & Labeling
      • Process Api & Formulation Development
      • Quality/Stability & Post-Market Support
      • Regulatory Affairs & Consulting
      • Veterinary Clinical Trials

      US: VETERINARY CONTRACT MANUFACTURING & RESEARCH MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      MID-SIZED/SPECIALTY ANIMAL HEALTH FIRMS90.999.2108.4118.4129.4141.5154.7169.19.3
      MULTINATIONAL ANIMAL HEALTH COMPANIES179.3191.2204.2218.2233.2249.3266.5285.16.9
      START-UPS & VETERINARY BIOTECH FIRMS26.129.232.736.640.945.851.357.511.9
      TOTAL296.3319.6345.3373.2403.5436.6472.5511.78.2

      Target Audience

      • Veterinary Pharmaceutical Companies : Manufacturers seeking outsourced contract manufacturing and research services need US market data to identify qualified CMOs, evaluate capacity availability, understand pricing dynamics, and optimize supply chain partnerships.
      • Contract Manufacturing Organizations (CMOs) : US-based CMOs require market intelligence on growth trends, competitive positioning, customer demand patterns, and capacity expansion opportunities to guide investment decisions and service development strategies.
      • Private Equity & Investment Firms : Investors evaluating acquisition targets or portfolio companies in veterinary contract manufacturing need comprehensive US market data, growth projections, and competitive analysis to assess investment returns and strategic value.
      • Regulatory & Compliance Consultants : Consultants advising veterinary pharmaceutical and manufacturing clients require detailed US regulatory landscape insights, market trends, and compliance requirements to provide strategic guidance and risk mitigation.
      • Market Research & Strategy Teams : Corporate strategy, business development, and market research professionals need validated US market data, forecasts, and competitive intelligence to support strategic planning, M&A evaluation, and market opportunity assessment.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise US market valuation ($345.3M in 2026) and verified 8.2% CAGR projections through 2031 to support investment decisions, business planning, and competitive positioning in the American veterinary contract manufacturing sector.
      • Regulatory & Compliance Insights : Understand FDA regulatory frameworks, quality standards, and compliance requirements specific to US veterinary contract manufacturing, enabling manufacturers to optimize operations and meet stringent domestic regulatory expectations.
      • Competitive Landscape Analysis : Identify key US-based contract manufacturers, market consolidation trends, and competitive dynamics to benchmark performance, identify partnership opportunities, and develop targeted market entry or expansion strategies.
      • Demand Drivers & Opportunity Mapping : Analyze specific US market drivers including companion animal therapeutics demand, livestock biologics growth, and specialized formulation requirements to identify high-potential market segments and revenue opportunities.
      • Strategic Planning & Forecasting : Leverage detailed US market forecasts and growth projections to inform long-term strategic planning, capital allocation, R&D investment priorities, and market expansion initiatives through 2031.

      Frequently asked questions

      What is the current size of the US veterinary contract manufacturing & research market?

      The US veterinary contract manufacturing & research market is estimated at $345.3 million in 2026.

      What is the projected market size for the US by 2031?

      The US market is forecast to reach $511.7 million by 2031, representing 48.2% growth over the five-year period.

      What is the CAGR for the US veterinary contract manufacturing & research market?

      The US market is expected to grow at a compound annual growth rate of 8.2% from 2026 to 2031.

      What factors are driving growth in the US veterinary contract manufacturing market?

      Key drivers include rising pet ownership, expanding livestock production, increased outsourcing by veterinary pharmaceutical companies, and growing demand for novel vaccines and therapeutics in the US.

      Why is the US a leading market for veterinary contract manufacturing?

      The US leads due to advanced manufacturing infrastructure, FDA regulatory expertise, established CRO/CMO capabilities, and strong relationships with major veterinary pharmaceutical firms.

      RESEARCH METHODOLOGY

      This research study extensively utilized both primary and secondary sources. It involved analyzing various factors that influence the industry to identify segmentation types, industry trends, key players, competitive landscape, key market dynamics, and the strategies employed by key players.

      Secondary Research

      This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the veterinary contract manufacturing & research market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments about both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

      Primary Research

      In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development, and operations managers, as well as presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary contract manufacturing & research market. Primary sources from the demand side include R&D scientists and researchers in animal health companies, veterinary clinicians, and veterinary biotech firms developing veterinary therapeutics and technologies.

      Veterinary Contract Manufacturing and Research Market 
 Size, and Share

      Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
      Note 2: Other designations include sales, marketing, and product/service managers.

      Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the veterinary contract manufacturing & research market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.

      Veterinary Contract Manufacturing and Research Market Top Down and Bottom Up Approach

      Data Triangulation

      After arriving at the veterinary contract manufacturing & research market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and obtain precise statistics for all segments and subsegments.

      Market Definition

      The veterinary contract research organization (CRO) market comprises third-party service providers that support animal-health companies in the outsourced research and development of veterinary pharmaceuticals, biologics, vaccines, and related products. Veterinary CROs provide services across the product lifecycle, including discovery support, preclinical studies, target animal safety, clinical field trials, bioequivalence studies, regulatory consulting, and post-approval research, in compliance with veterinary regulatory standards. These services are primarily used by animal-health pharmaceutical companies, biotechnology firms, and vaccine developers to reduce development timelines, access specialized expertise, manage regulatory complexity, and optimize R&D costs without maintaining a complete in-house research infrastructure. The veterinary contract development and manufacturing organization (CDMO) market consists of third-party manufacturers that provide outsourced development, scale-up, and commercial manufacturing services for veterinary drugs, biologics, vaccines, and related products. Veterinary CDMOs support animal-health companies through process and formulation development, API and finished dosage form manufacturing, fill-finish operations, packaging and labeling, quality control, stability testing, and regulatory manufacturing support, operating in accordance with veterinary GMP and biologics regulations.

      These services enable animal-health companies to outsource capital-intensive manufacturing activities, increase production flexibility, manage capacity constraints, and accelerate market entry, particularly for complex formulations, sterile injectables, and veterinary vaccines.

      Key Stakeholders

      • Animal-health pharmaceutical companies
      • Veterinary biotechnology companies
      • Veterinary biologics & vaccine developers
      • Veterinary contract development & manufacturing organizations (CDMOs)
      • Veterinary contract research organizations (CROs)
      • Preclinical & toxicology research laboratories (GLP & non-GLP)
      • Clinical trial management organizations for veterinary studies
      • Regulatory consulting firms specializing in VICH / EMA / FDA-CVM
      • Quality control & analytical testing laboratories (veterinary-focused)
      • Veterinary formulation & process development service providers
      • Packaging, filling, and labeling service providers for veterinary products
      • Animal research facilities & field trial centers
      • Veterinary academic research institutes
      • Livestock research institutions & herd-health trial networks
      • Raw material suppliers for veterinary APIs, excipients, and biologics components

      Report Objectives

      • To define, describe, segment, and forecast the veterinary contract manufacturing & research market by service, product type, animal type, end user, and region
      • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall veterinary contract manufacturing & research market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the veterinary contract manufacturing & research market in five central regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the veterinary contract manufacturing & research market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments such as acquisitions, service launches, expansions, collaborations, agreements, and partnerships

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

      Company Information
      • Detailed analysis and profiling of additional market players (up to 5)

      Geographic Analysis

      • Further breakdown of the Rest of Europe veterinary contract manufacturing & research market into Austria, Finland, Switzerland, and other countries
      • Further breakdown of the Rest of Latin American veterinary contract manufacturing & research market into Colombia, Chile, and other countries
      Competitive Landscape Assessment
      • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the veterinary contract manufacturing & research market
      • Competitive leadership mapping for established players in the US

       

      Get the Full Veterinary Contract Manufacturing & Research Market Report

      Full forecast, segment splits, and company analysis for all Veterinary Contract Manufacturing & Research Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status